Growth Metrics

Caribou Biosciences (CRBU) Receivables - Net (2020 - 2025)

Caribou Biosciences has reported Receivables - Net over the past 6 years, most recently at $69000.0 for Q4 2025.

  • Quarterly Receivables - Net fell 73.96% to $69000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $69000.0 through Dec 2025, down 73.96% year-over-year, with the annual reading at $69000.0 for FY2025, 73.96% down from the prior year.
  • Receivables - Net was $69000.0 for Q4 2025 at Caribou Biosciences, down from $242000.0 in the prior quarter.
  • Over five years, Receivables - Net peaked at $1.5 million in Q1 2023 and troughed at $2000.0 in Q2 2021.
  • The 5-year median for Receivables - Net is $265000.0 (2024), against an average of $466368.4.
  • Year-over-year, Receivables - Net surged 26100.0% in 2022 and then plummeted 90.4% in 2025.
  • A 5-year view of Receivables - Net shows it stood at $1.2 million in 2021, then plummeted by 82.48% to $202000.0 in 2022, then fell by 26.73% to $148000.0 in 2023, then soared by 79.05% to $265000.0 in 2024, then plummeted by 73.96% to $69000.0 in 2025.
  • Per Business Quant, the three most recent readings for CRBU's Receivables - Net are $69000.0 (Q4 2025), $242000.0 (Q3 2025), and $71000.0 (Q2 2025).